Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient

Abstract

A Japanese female patient with angioimmunoblastic T cell lymphoma underwent allogeneic bone marrow transplantation (BMT) from her brother. Cyclosporine at a dose of 3 mg/kg was started by continuous infusion over 24 h on day −1 of BMT. Within a couple of minutes after the infusion was begun, she developed diffuse pruritic erythema on her whole body and tachycardia. The infusion was immediately stopped and corticosteroid was given, resulting in disappearance of the erythema gradually. She was then switched to intravenous tacrolimus. However, she suffered urticalial erythema again. Since polyoxyethylated castor oil, a solubilizer used in the injective formulation of both cyclosporine and tacrolimus, is considered to be responsible for the reaction, she was given oral capsules of cyclosporine (Sandimmun) in which polyoxyethylated castor oil was not contained. No further anaphylactic reaction was observed. The BM cells were successfully engrafted without causing severe GVHD. She was discharged on cyclosporine capsules without any further adverse effects. Anaphylaxis to intravenous cyclosporine and tacrolimus is a very rare but a serious complication. Our present case indicates that oral capsule of Sandimmun is a safe alternative to prevent GVHD in such a case of anaphylactic reaction against intravenous formulation. Bone Marrow Transplantation (2001) 28, 421–423.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ringden O . Cyclosporine in allogeneic bone marrow transplantation Transplantation 1986 42: 445–452

    Article  CAS  PubMed  Google Scholar 

  2. Kahan BD, Wideman CA, Flechner S et al. Anaphylactic reaction to intravenous cyclosporin Lancet 1984 1: 52

    Article  CAS  PubMed  Google Scholar 

  3. Friedman LS, Dienstag JL, Nelson PW et al . Anaphylactic reaction and cardiopulmonary arrest following intravenous cyclosporine Am J Med 1985 78: 343–345

    Article  CAS  PubMed  Google Scholar 

  4. Rowinsky EK, Eisenhauer EA, Chaudhry V et al. Clinical toxicities encountered with paclitaxel (TAXOL) Semin Oncol 1993 20: (Suppl. 3) 1–15

    CAS  PubMed  Google Scholar 

  5. Mounier P, Laroche D, Divanon F et al. Anaphylactoid reactions after intravenous infusion of a cremophor-containing solution of multivitamins Therapie 1995 50: 571–573

    CAS  PubMed  Google Scholar 

  6. Bullen AW, Miller JP, Cunliffe WJ et al. Skin reactions caused by vitamin K in patients with liver disease Br J Dermatol 1978 98: 561–565

    Article  CAS  PubMed  Google Scholar 

  7. Pratschke J, Neuhaus R, Tullius SG et al. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation Transplantation 1997 64: 938–940

    Article  CAS  PubMed  Google Scholar 

  8. van Hooff JP, Bessems P, Beuman GH et al. The absence of an allergic reaction to cyclosporine capsules in a patient allergic to standard oral and intravenous solution of cyclosporine Transplant Proc 1988 20: (Suppl. 2) 640

    CAS  PubMed  Google Scholar 

  9. Cooney GF, Alpern JB, Narins BE et al. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug Transplantation 1990 49: 823–824

    Article  CAS  PubMed  Google Scholar 

  10. Rakhmanina N, Barnes C, Dowing P et al. Anaphylactoid reaction to intravenous cyclosporine in a child J Aller Clin Immunol 1997 99: S433

    Google Scholar 

  11. Volcheck GW, van Dellen RG . Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review Ann Aller Asthma Immunol 1998 80: 159–163

    Article  CAS  Google Scholar 

  12. Kuiper RAJ, Malingre MM, Beijnen JH et al. Cyclosporine-induced anaphylaxis Ann Pharmacother 2000 34: 858–861

    Article  CAS  PubMed  Google Scholar 

  13. Ptachcinski RJ, Gray J, Venkataramanan R et al. Anaphylactic reaction to intravenous cyclosporine Lancet 1985 1: 636–637

    Google Scholar 

  14. Chapuis B, Helg C, Jeannet M et al. Anaphylactic reaction to intravenous cyclosporine New Engl J Med 1985 312: 1259

    CAS  PubMed  Google Scholar 

  15. Habboush HW, Hann IM . Anaphylactic reaction to cyclosporin in a bone marrow transplant recipient Br J Haematol 1986 62: 195–199

    Article  CAS  PubMed  Google Scholar 

  16. Howrie DL, Ptachcinski RJ, Griffith BP et al. Anaphylactoid reactions associated with parenteral cyclosporine use: possible role of cremophor EL Drug Intell Clin Pharm 1985 19: 425–427

    Article  CAS  PubMed  Google Scholar 

  17. Leunissen KM, Waterval PWG, van Hooff JP . Anaphylactic reaction to intravenous cyclosporine Lancet 1985 1: 636 (Abstr.)

    Article  Google Scholar 

  18. Magalini SC, Nanni G, Agnes S et al. Anaphylactic reaction to first exposure to cyclosporine Transplantation 1986 42: 443–444 (Abstr.)

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takamatsu, Y., Ishizu, M., Ichinose, I. et al. Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient. Bone Marrow Transplant 28, 421–423 (2001). https://doi.org/10.1038/sj.bmt.1703161

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703161

Keywords

This article is cited by

Search

Quick links